Alanylation of Teichoic Acids Protects Staphylococcus aureus against Toll-like Receptor 2-Dependent Host Defense in a Mouse Tissue Cage Infection Model by Kristian, Sascha A. et al.
414 • JID 2003:188 (1 August) • Kristian et al.
M A J O R A R T I C L E
Alanylation of Teichoic Acids Protects Staphylococcus
aureus against Toll-like Receptor 2–Dependent
Host Defense in a Mouse Tissue Cage
Infection Model
Sascha A. Kristian,1,2,4 Xavier Lauth,3 Victor Nizet,3 Friedrich Goetz,1 Birgid Neumeister,2 Andreas Peschel,1
and Regine Landmann4
1Microbial Genetics, University of Tu¨bingen, and 2Department of Transfusion Medicine, University Hospitals Tu¨bingen, Tu¨bingen, Germany;
3Division of Pediatric Infectious Diseases, University of California, San Diego; 4Division of Infectious Diseases, Department of Research,
University Hospitals Basel, Basel, Switzerland
Staphylococcus aureus is inherently resistant to cationic antimicrobial peptides because of alanylation of cell
envelope teichoic acids. To test the effect of alanylated teichoic acids on virulence and host defense mediated by
Toll-like receptor 2 (TLR2), wild-type (wt) S. aureus ATCC35556 (S.a.113) and its isogenic mutant expressing
unalanylated teichoic acids (dlt) were compared in a tissue cage infection model that used C57BL/6 wt and
TLR2-deficient mice. The minimum infective doses (MID) to establish persistent infection with S.a.113 were 103
and 102 colony-forming units (cfu) in wt and TLR2/ mice, respectively. The corresponding MID for dlt were
and 103 cfu in wt and TLR2/ mice, respectively. Both mouse strains showed bacterial-load–dependent55 10
inflammation with elevations in tumor necrosis factor, macrophage inflammatory protein 2, and leukocytes, with
increasing proportions of dead cells. These findings indicate that alanylated teichoic acids contribute to virulence
of S. aureus, and TLR2 mediates host defense, which partly targets alanylated teichoic acids.
Staphylococcus aureus is a leading cause of community-
acquired infections of the skin, soft tissue, musculoskele-
tal system, respiratory tract, and endovascular system, as
well as hospital-acquired bacteremias and device-asso-
ciated infections [1]. As a prerequisite to establishing
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invasive infection, S. aureus has evolved means to cir-
cumvent host defenses [1–3]. These host defense rec-
ognition and evasion strategies of S. aureus are incom-
pletely understood [4].
Cationic antimicrobial peptides (CAMPs), such as de-
fensins, cathelicidins, and thrombocidins, represent an
important oxygen-independent defense mechanism of
the innate immune system of mammals to combat in-
vading pathogens [5, 6]. Defensins are found in various
human tissues and in neutrophils [7]; cathelicidins, in-
cluding human LL-37 and mouse cathelin-related anti-
microbial peptide (CRAMP) [8], are produced by ker-
atinocytes and polymorphonuclear neutrophils (PMNs).
S. aureus is inherently resistant to the antimicrobial ac-
tion of defensins [3, 9] and other CAMP [3]. Esterifi-
cation of cell-envelope components with amino acids
most likely represents one important determinant of this
resistance [5]; such modifications lead to a decrease in
the net negative surface charge of the bacteria and con-
sequently to the repulsion of CAMP [10, 11].
We have previously described an operon on the S.
aureus chromosome, dltABCD, the products of which
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catalyze the introduction of D-alanine into teichoic acids,
staphylococcal cell envelope polymers [10]. We showed that S.
aureus dlt knockout (dlt) bacteria are highly susceptible to
isolated CAMP and oxygen-independent killing mechanisms of
neutrophils in vitro [12]. Both S. aureus and Listeria mono-
cytogenes dlt bacteria were shown to be virulence attenuated
in murine sepsis models [12, 13]. However, it remained un-
proven whether this virulence attenuation reflected the ability
of teichoic acid alanylation to protect the bacteria from leu-
kocyte-dependent killing in vivo. To specifically address this
key issue, the present study compared the virulence of S. aureus
wild-type and dlt bacteria in a mouse tissue cage infection
model [14, 15]. This model was chosen because it reproduces
the common characteristics of device-associated infections
where S. aureus is among the most frequently isolated patho-
gens [16]. These infections are characterized by a low initial
infecting inoculum of microorganisms, by the absence of spread
beyond the vicinity of the foreign body, and by a chronic evo-
lution until removal of the prosthesis [15]. A potential reason
for the persistence of infection is biofilm formation by the
bacteria. Because dlt bacteria exhibit a dramatic reduction in
their ability to colonize artificial surfaces and to form biofilm
in vitro [17], additional interest to study the virulence of dlt
S. aureus in the tissue cage system is provided. We adapted the
guinea pig tissue cage model [14, 18, 19] for the mouse, in
which leukocyte host-defense mechanisms can be monitored
and animals with targeted gene deletions are available for func-
tional studies.
Finally, to identify precise molecular mechanisms by which
teichoic acid alanylation allows S. aureus to evade host defense,
we selected the host pattern recognition receptor Toll-like re-
ceptor 2 (TLR2) for study [20, 21]. When studied in vitro,
TLR2 confers responsiveness of host leukocytes to heat-killed,
gram-positive bacteria, including S. aureus, and to purified cell
walls, peptidoglycan, lipoteichoic acid (LTA), or bacterial lipo-
proteins. After stimulation with these components, TLR2 me-
diates NF-kB translocation [22, 23] and cytokine or defensin
release [24, 25]. A protective role of TLR2 has been demon-
strated in murine models of S. aureus sepsis [26] and Strep-
tococcus pneumoniae meningitis [27]. However, it is not known
which TLR2 ligand plays the major role in S. aureus–induced
inflammation in vivo and whether TLR2 participates in non-
oxidative antimicrobial defense mechanisms to which S. aureus
with unalanylated teichoic acids are particularly sensitive. These
questions were addressed by comparing the host inflammato-
ry response to wild-type (wt) and dlt S. aureus in C57BL/6 wt
and TLR2/ mice.
MATERIALS AND METHODS
Preparation of staphylococcal strains. S. aureus ATCC35556
(S.a.113) [28] and isogenic dltA bacteria were used for ex-
perimental infection of the animals. The procedures used for
disruption of the dltABCD operon, for plasmid construction,
and for phenotypic and genotypic characterizations of dlt have
been described in detail elsewhere [10]. The staphylococcal
strains were grown overnight in tryptic soy broth at 37C with-
out shaking, subsequently washed 3 times in large volumes of
0.9% NaCl (pH 7.4), and resuspended in saline immediately
before use.
Mice and tissue cage model. We kept 12–16-week-old fe-
male C57BL/6 wt mice (purchased from RCC) and TLR2/
mice, which had been backcrossed for 6 generations on a
C57BL/6 background, under specific pathogen–free conditions
in the Animal House of the Department of Research, University
Hospitals Basel, according to the regulations of the Swiss vet-
erinary law. Mice were anesthetized via intraperitoneal injection
of 100 mg/kg ketamine (Ketalar; Warner-Lambert) and 20 mg/
kg xylazinum (Xylapan; Graeub), and a sterile tissue cage was
implanted subcutaneously in the back [29, 30]. The cages (in-
ternal and external diameters, 8 and 10 mm, respectively; length,
30 mm; internal volume, 1.84 mL) were identical to those used
in the guinea pig foreign body infection model, as described
elsewhere [15], and consisted of closed polytetrafluoroethylene
Teflon cylinders with 130 regularly spaced 0.2-mm holes and
contained 8-sinter glass beads. After surgery, mice were treated
with buprenorphine (2 mg/kg subcutaneously twice daily) for
48 h to treat postoperative pain.
Two weeks after surgery, sterility of the tissue cage was ver-
ified, and 200 mL of suspensions of S. aureus was injected per-
cutaneously with 25-gauge needles. As reported with tissue cage
infections in guinea pigs [15], mice never developed bacteremia
and showed no weight change during 3 weeks of infection.
Immunosuppression of mice with cyclophosphamide.
Mice were treated with cyclophosphamide (200 mg/kg intra-
peritoneally [ip]) or as control with saline (ip) every 48 h
starting 2 days before experimental infection.
Sampling of tissue cage fluid (TCF). Mice were anesthe-
tized by inhalation of isofluorane (Abbott); 150-mL samples of
TCF were drawn by percutaneous aspiration and transferred
into sterile microreaction tubes containing 15 mL of 0.9% NaCl
and 1.5% EDTA (pH 7.4), to avoid clotting. In selected ex-
periments, the pH of TCF samples was measured with pH
indicator strips (Merck).
Quantification of planktonic and adherent bacteria. To
determine the load of planktonic (free-floating) bacteria in TCF,
serial dilutions of the samples were plated on Mueller-Hinton
broth (MHB) agar plates. Colony-forming units were enu-
merated after 24-h incubation at 37C. To quantify the number
of adherent staphylococci in the Teflon cages and on the glass
beads, we used a method described elsewhere [31]. In brief,
mice were killed, and tissue cages were explanted under sterile
conditions 6 h to 21 days after infection. Glass beads and cages
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Figure 1. In vivo bacterial growth for 21 days after infection with
or cfu of either Staphylococcus aureus3 35.3 2.7 10 7.7 2.3 10
ATCC35556 (S.a.113) () or S. aureus ATTC35556 dltA knockout bacteria
(dlt) (), respectively. Data are from at least 7 experiments.mean SD
* ; ** (analysis of variance repeated measurements).P ! .05 P ! .005
were washed 3 times with saline and separately transferred into
glass tubes containing 2–4 mL of 0.9% NaCl, EDTA (0.15%),
and Triton-X (0.1%) (pH 7.4). The tubes were vortexed vig-
orously for s, placed into an ultrasonic bath, and son-3 15
icated for 3 min at 200 W (Labsonic 2000; Bender & Hohbein).
More than 95% of adherent S. aureus can be detached by this
procedure [15]. After additional vortexing, appropriate vol-
umes of serial dilutions were spread on MHB agar plates to
quantify colony-forming units.
Counting of leukocytes, quantification of viable leukocytes,
and identification of cell type in TCF. Leukocytes were quan-
tified with a Coulter counter (Coulter Electronics). The per-
centage of viable leukocytes was assessed by trypan blue exclu-
sion. Leukocyte differentiation in TCF was performed by Diff-
Quick (Dade Behring) staining of cytospins and examination
under high-power light microscopy.
Leukocyte viability in infected TCF. TCF of uninfected
and infected mice (14 days after infection) was pooled sepa-
rately and centrifuged at 400 g for 10 min to remove cellular
host components. Infected TCF was rendered free of residual
thrombocytes and bacteria by centrifugation for 5 min at 25,000
g. Pelleted cells of uninfected TCF were then resuspended in
supernatants of infected cell-free TCF. After 6-h incubation at
37C with gentle shaking in sterile 14-mL polypropylene tubes,
the viability of leukocytes was assessed as described above.
Cytokine assays. Measurement of tumor necrosis factor
(TNF) and macrophage inflammatory protein (MIP)–2 in the
supernatants of the samples were carried out by sandwich ELISAs
that used the OptEIA mouse TNF set (PharMingen) and the
Quantikine M mouse MIP-2 set (R&D Systems), respectively.
FACScan analysis. Phenotypes of TCF leukocytes were
analyzed by FACS after staining with the following antibodies
[32]: anti-CD11b (MAC-1; Pharmingen) and anti-CD16/CD32
(FcgII/III receptor; Pharmingen). Rat IgG2b (Pharmingen) was
used as isotype control. Fluorescein-conjugated goat anti–rat
IgG (Jackson Laboratories) was used as secondary antibody.
In vitro growth of staphylococci in TCF. S.a.113 and dlt
bacteria were grown and washed as described above and ad-
justed to cfu/mL in 100-mL pooled uninfected TCF,3∼ 5 10
from which cellular components were removed by centrifuga-
tion at 400 g for 10 min and incubated at 37C without shaking.
After 24 h, 50 mL of serial dilutions was spread on MHB agar
plates to quantify colony-forming units.
Susceptibility of S.a.113 and dlt to gallidermin and
CRAMP. For bacterial susceptibility testing to gallidermin,
TCF of wt or TLR2/ mice containing S.a.113 or dlt was
drawn 3 weeks after infection. In parallel, in vitro cultures of
S.a.113 and dlt were grown in tryptic soy broth and washed
as described above. Bacteria were adjusted to cfu/mL41–2 10
by dilution in saline. We plated 100 mL of this suspension on
agar containing 0–8 mg/mL gallidermin and incubated them
for 24 h at 37C. Determination of the MIC and MBCs of
CRAMP against S.a.113 or dlt bacteria was performed as de-
scribed elsewhere for Streptococcus pyogenes [33].
Statistical analysis. Results of bacterial growth, TNF and
MIP-2 levels, leukocyte numbers, and proportion of leukocytes
alive were compared by analysis of variance for repeated mea-
surements. was considered to be statistically significant.P ! .05
RESULTS
Staphylococcal growth in wt mice infected with S.a.113 or dlt
bacteria. Our previous results in a mouse sepsis model re-
vealed attenuated virulence of S. aureus dltA knockout bacteria
(dlt), which lack D-alanine modifications in teichoic acids,
compared with wt S. aureus [12]. To characterize local host
defense mechanisms to which dlt bacteria are more susceptible
than wt S. aureus (S.a.113), we adapted a guinea pig tissue cage
model [14, 15, 19] to the mouse. Tissue cages implanted in wt
mice were experimentally infected with S.a.113 or dlt, and the
course of disease was compared over a period of 3 weeks. Tis-
sue cage infections in guinea pigs can be established with a low
inoculum (e.g., 100–1000 cfu) for most S. aureus strains [15].
Similarly, the minimum infective dose (MID) of S.a.113 for
induction of persistent infections in wt mice was found to be
low ( cfu). In subsequent experiments, an inoculum of31 10
to cfu of S.a.113 was used to ensure coloni-35.3 2.7 10
zation of tissue cages. S.a.113 showed in vivo growth and per-
sistence in 10 of 10 experiments (figure 1), multiplied to
cfu/mL within 3 days, and reached a plateau of growth61 10
at around cfu/mL within 6–9 days. It remained at a75 10
constant density until day 21. In contrast to S.a.113, dlt bac-
teria were cleared from tissue cages in all experiments (np
) after delivery of a similar inoculum ( cfu). In37 7.7 2.3 10
6 of 7 experiments, no bacteria could be detected in TCF within
2 days (figure 1).
Alanylation of Teichoic Acids • JID 2003:188 (1 August) • 417
Figure 2. Tumor necrosis factor (TNF) concentration (A); macrophage inflammatory protein (MIP)–2 concentration (B); leukocyte count (C); and
proportion of viable leukocytes (D) in tissue cage fluid 21 days after infection with either Staphylococcus aureus ATCC35556 (S.a.113) () or S. aureus
ATTC35556 dltA knockout bacteria (dlt) () bacteria. Data are of at least 7 experiments in each group. * ; ** (analysismean SD P ! .05 P ! .005
of variance repeated measurements).
Quantification of planktonic bacteria does not take into ac-
count bacteria adhering to the inner surface of the implants
and on the glass beads in the cages. Moreover, in the guinea
pig model, staphylococci were shown to persist on the tissue
cage surface, despite sterile TCF [34]; therefore, surface-ad-
herent S.a.113 and dlt bacteria were quantified 3–21 days after
infection (data not shown). Surface-adherent bacteria were
never found in the presence of sterile TCF, indicating that wt
mice infected with dlt bacteria were completely cured within
1–6 days. Samples from the bacterial preparations of the 2
staphylococcal strains grew equally well in MHB in vitro, in-
dicating a similar fitness before infection (data not shown).
Because we did not obtain infection with 103 cfu of dlt, the
MID of dlt was ascertained by serially increasing the inocu-
lum in log steps. The dlt inoculum necessary to establish a
persistent infection was found to be between and55 10
cfu, 500–1000-fold higher than the MID of S.a.113.61 10
Infective doses of dlt bacteria showed growth behavior similar
to S.a.113 (data not shown), excluding differences in bacterial
replication responsible for the disparity in MID. The higher
MID of dlt bacteria in the tissue cage model identifies teichoic
acid alanylation as a virulence factor of S. aureus in foreign
body infections.
Phenotypic and functional host responses of wt mice during
infection with S.a.113 or dlt. To understand the contri-
bution of host inflammatory responses to differences in vivo
survival of S.a.113 and dlt, several parameters of host response
were monitored in wt mice inoculated with the above-men-
tioned cfu of either bacterial strain. Leukocyte via-35–8 10
bility was evaluated, because killing of eukaryotic cells by staph-
ylococci is known to occur [35]. Baseline leukocyte counts in
the range of cells/mL were found in un-4 31.4 10  4.6 10
infected tissue cages and they were composed of a larger PMNs
( ) and a smaller monocyte ( ) fraction.70% 6% 24% 6%
These results are in agreement with those of previous reports
[14, 30].
TNF release into S.a.113-infected cages was biphasic (figure
2A). A first peak with a mean value of 500 pg/mL was observed
on day 1 in 5 of 10 mice, and a second peak with values between
800 and 1000 pg/mL occurred between days 7 and 10. After
infection with dlt, only 3 of 7 mice had detectable TNF ele-
vations; the average levels of TNF were much lower than after
S.a.113 infection (figure 2A). Thus, TNF release correlated with
the level and persistence of the bacterial load.
Leukocyte activation was further assessed by measuring ex-
pression of the cell surface receptors CD11b, representing the
b-chain of the complement receptor CR3, and CD16/CD32,
which is representative of FcgII/III receptors. Both receptors,
which are involved in phagocytosis [36] and expressed in mono-
nuclear and PMNs cage leukocyte populations, were measured
before and 24 h after infection. The percentage of CD11b- and
CD16/CD32-positive leukocytes remained constant at 90% and
96%, respectively, after infection with either S.a.113 or dlt
bacteria. The mean fluorescence intensity of CD11b-positive
cells increased -fold and -fold 24 h af-1.39 0.28 1.42 0.13
ter infection in S.a.113- and dlt-infected cages, respective-
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Figure 3. Effect of in vivo leukocyte depletion on bacterial growth in
tissue cages. Growth of Staphylococcus aureus ATCC35556 (S.a.113)
(black symbols) and S. aureus ATTC35556 dltA knockout bacteria (dlt)
(white symbols) bacteria in wild-type mice treated with saline (circles)
or with cyclophosphamide (triangles). Results are colony-forming unit
values of 1 representative experiment.
ly, whereas the expression of CD16/CD32 remained unaltered
-fold and -fold, respectively). The re-(0.88 0.14 1.05 0.17
sults indicate that complement receptor upregulation was trig-
gered independently of the virulence potential of the bacteria.
In humans, neutrophil accumulation is induced by IL-8. IL-
8 has not been found in mice, but MIP-2 may serve as a neu-
trophil chemotactic factor with homologous function, as shown
in a murine lung injury model [37]. After infection with
S.a.113, the concentrations of MIP-2 in TCF increased steadily
from day 1 to day 21 (figures 2B). In contrast, the dlt mutant
did not induce MIP-2, except for one mouse, which showed a
modest release of MIP-2 beyond day 14 despite a sterile TCF.
Elevated MIP-2 levels were followed by an influx of leukocytes
into S.a.113-infected cages (figure 2C). The proportion of
PMNs increased from before infection to70% 6% 83%
between day 2 and day 21 after infection, corroborating a1%
role for MIP-2 in neutrophil attraction in vivo. Cells migrated
slowly into S.a.113-infected cages up to day 6 after infection
but rapidly increased thereafter, culminating in a -26.7 15.7
fold increase of total leukocyte numbers 21 days after infection.
The leukocyte influx was completely absent (figure 2C), and
the proportional changes among PMNs and monocytes did not
appear (data not shown) in dlt-infected tissue cages, which is
in agreement with the low MIP-2 levels observed in these mice.
Beginning at day 3 after infection with S.a.113, when bacteri-
al colony-forming unit and leukocyte counts had reached
∼ /mL and /mL, respectively, the proportion of vi-6 41 10 2 10
able leukocytes steadily decline from to95% 3% 48%
through day 21 after infection (figure 2D). Because of the10%
increasing proportions of dead cells, viable leukocyte numbers
increased only 13-fold during the 3 weeks of infection. In con-
trast, all leukocytes in dlt-infected cages remained alive. Cell
death in cages infected with S.a.113 could not be attributed to
an altered pH, because pH values remained constant at 7.8
throughout the 21-day infection period. Furthermore, cell0.3
death was unlikely to be due to S. aureus–derived exotoxins [38],
known to act rapidly [38], because uninfected cage leukocytes
were not lysed during a 6-h incubation with infected cell-free
TCF (data not shown).
In summary, several parameters of the host inflammatory
response in the tissue cages were linked to growth and persis-
tence of S.a.113 bacteria, absent in the dlt-infected mice.
Role of leukocytes in host defense against dlt bacteria.
We showed that S.a.113 and dlt have similar growth properties
in MHB medium in vitro. In contrast, we found the MID for
dlt bacteria is much higher than that for S.a.113. We therefore
tested whether dlt bacteria were more susceptible to soluble
factors and/or to leukocytes present in TCF. S.a.113 and dlt
grew similarly when cultured in vitro in TCF of uninfected
mice after removing cellular components by centrifugation
(data not shown). This finding indicates that the clearing of
dlt bacteria in wt mice was due to cell-associated host factors
absent in uninfected, cell-free TCF.
To prove an essential role for leukocytes in clearance of dlt
bacteria, wt mice were rendered leukopenic by means of the
immunosuppressive drug cyclophosphamide. Cyclophospha-
mide injections reduced leukocyte numbers in uninfected cages
by 75% to leukocytes/mL. As shown in3 33.5 10  1.6 10
figure 3, dlt bacteria were no longer cleared in leukopenic wt
mice and grew at a similar rate as S.a.113. These results strongly
suggest that leukocytes mediate the host defense against S. au-
reus in tissue cage infections.
Role of TLR2 in host defense against dlt bacteria.
TLR2/ mice were shown to be highly susceptible to infection
by S. aureus [26] and S. pneumoniae [27]. We tested whether
TLR2 participates in the immune defense against S.a.113 and
dlt bacteria during tissue cage infection by comparing the course
of disease in wt and TLR2/ mice. First, the MIDs for S.a.113
and dlt were determined in TLR2/ mice. The average MIDs
of 102 cfu (S.a.113) and 103 cfu (dlt) in TLR2/ mice (figure
4A) were 10-fold ( ) and 500–1000-fold lower, respectively,P ! .05
than those observed in wt mice (table 1). Thus, TLR2 is involved
in murine host defense against S. aureus in tissue cage infections,
and its role is prominent in the rapid clearance of dlt bacteria
by wt mice. However, even in TLR2/ mice, dlt bacteria had
a 10-fold higher MID than S.a.113 (table 1, figure 4A). This
reflects a higher susceptibility of the mutant bacteria to additional
host defense mechanisms not related to TLR2.
Course of disease in TLR25/5 mice. To assess the evolution
of infection in the absence of TLR2-mediated defense mech-
anisms, TLR2/ mice were infected with the same inocula of
S.a.113 and dlt as used in the wt mice challenges. As shown
in figure 4B, S.a.113 grew in TLR2/ mice and reached a
plateau of growth 3 days after infection. The bacterial growth
rate was faster than that observed in wt mice, where colony-
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Figure 4. A, Determination of the minimum infective dose of Staphylococcus aureus ATCC35556 (S.a.113) and S. aureus ATTC35556 dltA knockout
bacteria (dlt) in Toll-like receptor 2 (TLR2)–deficient mice. Mice were infected with 101 cfu (circles), 102 cfu (triangles), or 103 cfu (squares) of S.a.113
(black symbols) or dlt bacteria (white symbols), respectively. Results of 1 representative experiment of 2 performed are shown. B, Effect of TLR2
deficiency on growth of S.a.113 () or dlt bacteria (). Data are the geometric mean of at least 7 experiments in each group. * (analysisP ! .05
of variance repeated measurements).
Table 1. Minimum infective doses (MIDs) of Staphylococcus
aureus in 2 kinds of mice.
S. aureus strain
MID, cfu
wt mice TLR2/ mice
S.a.113 1  103 (n p 4) 1  102 (n p 3)a
dlt 5  105 to 1  106 (n p 5) 1  103 (n p 2)
NOTE. Average cfu counts, which caused a persistent infection, were
set as MID. In each experiment, inocula ranging from 101 to 106 cfu were
used to infect the tissue cages of wild-type and Toll-like receptor 2 deficient
(TLR2/) mice. dlt, S. aureus ATTC35556dltA knockout bacteria; S.a.113, S.
aureus ATCC35556; wt, C57BL/6 wild type.
a cfu counts required for infection were compared by Mann-Whitney U test;
the difference for S.a.113 between wild-type and TLR2/mice was significant
( ).P ! .05
forming unit counts were maximal only after 6–9 days (figures
4 and 1). The dlt bacteria, which were cleared in wt mice
(figure 1), proliferated in TLR2-deficient hosts ( ; figurenp 7
4B), thus identifying a role of TLR2 in murine immune defense
against bacteria expressing unalanylated teichoic acids. Nev-
ertheless, the dlt bacteria showed significantly delayed growth,
compared with wt bacteria ( ; figure 4B), reaching max-P ! .01
imum levels on day 14—that is, 11 days later than S.a.113.
TCF from untreated TLR2/ mice showed 41.1 10 
leukocytes/mL with PMNs and35.2 10 74% 9% 17%
monocytes, which was similar to the values found in wt7%
mice. Furthermore, bacterial replication in the tissue cage elic-
ited an inflammatory response in the TLR2/ host similar to
that observed in wt mice. This response was characterized by
increasing concentrations of TNF (figure 5A) and MIP-2 (figure
5B), by leukocyte influx (figure 5C), and by a decrease in leu-
kocyte viability (figure 5D). However, for all parameters mea-
sured, infection with S.a.113 induced a stronger response than
did infection with the dlt mutant. The S.a.113-induced TNF
response was biphasic, with a high peak after 1 day and a plateau
from day 7 onward. In contrast, dlt infection induced TNF
only in the late phase, and average values were lower than in
S.a.113-infected mice (figure 5A). MIP-2 was also induced fas-
ter and significantly more strongly in S.a.113-infected than in
dlt-infected TLR2/ mice (figure 5B).
The delayed, weaker TNF and MIP-2 responses are most
likely the consequence of the slower growth of the mutant
bacteria in TLR2/ mice. Infection in TLR2/ mice was fol-
lowed by leukocyte influx. Total leukocyte counts in S.a.113-
and dlt-infected cages increased -fold and11.5 6.4 12.8
-fold 21 days after infection, respectively (figure 5C). How-5.5
ever, the maximum leukocyte concentration in TLR2/ mice
was lower ( leukocytes/mL) than that in wt mice52.8 10
( leukocytes/mL; figure 2C). Leukocyte influx was also55.9 10
accompanied by a decreasing fraction of living cells (figure 4E).
In S.a.113-infected cages, viability started to decline after day
2, whereas, in dlt-infected cages, it started to decrease after
day 7.
Susceptibility of S.a.113 and dlt to antibacterial pep-
tides. CAMPs are deployed by the innate immune system in
response to S. aureus infections. In a previous study, human
PMNs exhibited a stronger bactericidal activity in vitro toward
dlt bacteria than on wt S.a.113 [12]. This difference paralleled
the higher susceptibility of dlt to CAMP [12]. It is known that
TLRs participate in the induction of CAMP [25]. In tissue cages,
the majority of the cells are PMNs, which are known to release
a CAMP of the cathelicidin family, CRAMP [33]. Therefore,
we compared the susceptibility of S.a.113 and dlt bacteria to
CRAMP in vitro. The MICs and MBCs of CRAMP were 4-fold
lower for dlt, compared with S.a.113 (figure 6A). To confirm
a differential sensitivity of S.a.113 and dlt bacteria to CAMP
in vivo, the susceptibility of S.a.113 and dlt to gallidermin, a
CAMP of bacterial origin, was assessed after harvesting the
bacteria from cages 3 weeks after infection. The gallidermin
concentration required to kill 50% of the applied staphylococci
was ∼1 mg/mL for S.a.113 and !0.3 mg/mL for dlt bacteria
(figure 6B). This result supports a hypothesis that neutrophil-
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Figure 5. Course of disease in Toll-like receptor 2–deficient mice. A, Tumor necrosis factor (TNF) concentration; B, macrophage inflammatory protein
(MIP)–2 concentration; C, leukocyte counts; D, leukocyte viability in tissue cages during 21 days after infection with Staphylococcus aureus ATCC35556
(S.a.113) () or S. aureus ATTC35556 dltA knockout bacteria (dlt) () bacteria. Data are of at 7 least experiments in each group.mean SD
* ; ** (analysis of variance repeated measurements).P ! .05 P ! .005
derived CAMP such as CRAMP could be responsible for the
killing of dlt bacteria in tissue cages in wt mice.
DISCUSSION
In the present study, we investigated the role of the dltABCD-
mediated resistance against cationic antimicrobial host com-
ponents in S. aureus virulence, and we investigated whether
this immune escape mechanism protects against TLR2-depen-
dent host defense. In a mouse tissue cage infection model, we
found that alanylated teichoic acids protect against host de-
fense—in large part, those pathways mediated by TLR2.
S. aureus teichoic acids mediate resistance against host defense
by several mechanisms. Esterification of teichoic acids with ami-
no acids decreases the net negative surface charge of the staph-
ylococcal cells, thereby conferring resistance to CAMPs [10, 11]
and other nonoxidative antimicrobial effector mechanisms, in-
cluding phospholipase A2 [39]. Indeed, dlt
 bacteria with unala-
nylated teichoic acids are more susceptible to CAMP [10] and
phospholipase A2 [39]. Alanylation of teichoic acids also affects
the capacity of the bacteria to adhere on glass and plastic surfaces;
accordingly, dlt bacteria exhibit reduced adhesion to artificial
surfaces [17].
In this study, we investigated how alanylation of teichoic
acids affect S. aureus survival during a local infection in vivo.
Furthermore, teichoic acids were studied as potential targets of
the pattern recognition receptor TLR2, prompted by the fact
that purified LTA activates cells through TLR2 [22]. In contrast
to LTA, cell-wall teichoic acid has not yet been examined for
its interaction with TLR2. S. aureus cell-wall teichoic acid differs
from LTA in its lack of a lipid anchor and in the nature of its
repeating sugar units. Yet, we hypothesize that TLR2 is engaged
by both teichoic acid and LTA and that the TLR2-mediated
effector mechanisms are influenced by the charge (i.e., alanyla-
tion) of the 2 components. TLR2 has 2 important functions:
it transmits a proinflammatory signal in response to LTA, pep-
tidoglycan, or lipoprotein stimulation [22, 23, 40]; and it exerts
a protective role for the host during infection with S. aureus
and other gram-positive bacteria. The mechanism of this pro-
tective role remains unknown.
We found that dlt was less virulent than wt S.a.113, as
determined by the 500–1000-fold higher MID of the mutant
in wt mice. This finding indicates that the susceptibility to
oxygen-independent antimicrobial host mechanisms facilitates
bacterial clearing. Indeed, dlt were more sensitive to CRAMP
in vitro and gallidermin ex vivo. Future studies that use
CRAMP/ mice, which lack the mouse neutrophil cathelicidin
CRAMP [33], will address whether murine cathelicidins are
responsible for clearing of dlt in the tissue cage model. An
increased sensitivity to phospholipase A2, which we described
recently for dlt bacteria [39], could not explain clearing of the
dlt mutant in our model, because C57/BL6 mice are deficient
in phospholipase A2 [41]. It is also unlikely that dlt
 bacteria
were more sensitive to oxidative killing because they were
cleared equally in vivo in the presence and absence of the free
radical scavenger a-phenyl-ter-butylnitrone (data not shown),
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Figure 6. A, Susceptibility of Staphylococcus aureus ATCC35556 (S.a.113) (black bars) and S. aureus ATTC35556 dltA knockout bacteria (dlt)
(white bars) to mouse cathelicidin cathelin-related antimicrobial peptide (CRAMP), as assessed by the MIC and the minimum bactericidal concentration
(MBC) in vitro. Studies were performed in duplicate. B, Susceptibility of S.a.113 (black symbols) and dlt (white symbols) bacteria to gallidermin,
grown in vivo (circles) or in vitro (squares). Values of 1 representative experiment are expressed as percentages of cfu obtained on agar plates
containing no gallidermin.
an agent known to effectively decrease oxidative injury in group
B streptococcal meningitis [42]. Finally, clearing of dlt bacteria
is apparently not related to a reduced colonization on glass
surfaces in vivo, because no differences were found between
S.a.113 and dlt in adhesion.
Because dlt are more susceptible to CAMP, it was interesting
to investigate whether innate receptors, which are known to con-
tribute to CAMP release, participate in their elimination. TLR2
could play such a role, although so far only b-defensin was shown
to be induced via TLR2 [25] and this induction was measured
after stimulation with bacterial lipoprotein. Up-regulation of
cathelicidin expression after infection with live bacteria occurs
by an unknown mechanism. Future studies will address the ques-
tion whether TLR2 modulates cathelicidin release. We found the
MID of dlt was 1000-fold lower in TLR2/ mice than in wt
mice. Although 105 to 106 cfu were required in wt mice, only
103 cfu caused an infection in TLR2/ mice. This means that
TLR2 recognition and/or effector mechanisms are important in
the control of dlt bacteria. Of interest, dlt remained less virulent
than S.a.113 in TLR2/ mice, indicating that TLR2-independent
mechanisms also contribute to bacterial clearance.
Whether TLR2 participates directly in bacterial clearance is
not clear. It is unlikely that phagocytosis is influenced by TLR2,
because zymosan uptake in macrophages was shown to be TLR2
independent [43]. It is possible that engagement of TLR2 leads
to bacterial killing through an increased generation of CAMP,
via reactive oxygen species or via release of chemokines that
recruit additional leukocytes to the site of infection. Further-
more, TLR2 activation might induce killing via a nitric oxide–
dependent mechanism, as shown during infection with My-
cobacterium tuberculosis [44].
Our tissue cage model also demonstrates that TLR2 contrib-
utes moderately to efficient killing of S.a.113. The MID of S.a.113
was 10-fold lower in TLR2/ mice than in wt mice. Early S.a.113
growth was faster in the absence of TLR2. Comparison of S.a.113
and dlt in the 2 mouse strains implies that alanylated teicho-
ic acids protect S. aureus from TLR2-mediated defense. Three
mechanisms not mutually exclusive can be envisaged. First, dlt
bacteria may bind to host cell TLR2 more strongly than S.a.113.
Second, they may bind to other phagocytic receptors, which leads
to efficient clearing only in the presence of TLR2. Third, both
S.a.113 and dlt may activate leukocytes to an equivalent degree,
but the mutant may be killed faster and better because of its
increased susceptibility to CAMP. It remains to be determined
which of these mechanisms is TLR2 dependent.
Our results deserve 2 further comments. In tissue cage infec-
tion, the inflammatory response was very strong. However, the
onset of the inflammatory response was delayed and strictly cor-
related with bacterial number. Release of MIP-2 and TNF showed
a biphasic pattern. After 24 h of infection, small amounts of both
mediators were detected, and these levels were not associated
with cessation of bacterial growth. Of interest, this early initial
peak was present in TLR2/ mice and therefore is mediated by
TLR2-independent mechanisms. We also found an increased ex-
pression of CR3 during the early stage of infection in both mouse
strains, again independent of TLR2. The inflammation response
in this model was then characterized by a second phase with
release of extremely large amounts of MIP-2 and TNF, high
leukocyte numbers, and massive leukocyte cell death. This de-
layed and apparently insufficient response appears when the bac-
teria reach high numbers and does not affect bacterial clearance.
This phenomenon is likely a by-product of the closed infection
model and might resemble the pathophysiology of implant-as-
sociated infection in humans.
A final comment concerns the association of S. aureus viru-
lence with the expression of alanylated teichoic acids. In the tissue
cage model, bacteria have a growth advantage as a consequence
of the delayed inflammatory response. Nevertheless, S. aureus is
immediately cleared when it expresses unalanylated teichoic acids
that render them highly susceptible to the action of CAMP. Future
strategies that target enzymes encoded by the dltABCD operon
may be of benefit in therapy of S. aureus infection.
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